The store will not work correctly when cookies are disabled.
ID: ALA372907
Max Phase: Preclinical
Molecular Formula: C5H9NO3
Molecular Weight: 131.13
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC1(O)C(=O)NCC1O
Standard InChI: InChI=1S/C5H9NO3/c1-5(9)3(7)2-6-4(5)8/h3,7,9H,2H2,1H3,(H,6,8)
Standard InChI Key: TWPXBSBMIBIYCM-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 131.13 | Molecular Weight (Monoisotopic): 131.0582 | AlogP: -1.77 | #Rotatable Bonds: 0 |
Polar Surface Area: 69.56 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.88 | CX Basic pKa: | CX LogP: -1.78 | CX LogD: -1.78 |
Aromatic Rings: 0 | Heavy Atoms: 9 | QED Weighted: 0.36 | Np Likeness Score: 2.16 |
References
1. Coutrot P, Claudel S, Didierjean C, Grison C.. (2006) Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one., 16 (2): [PMID:16271473] [10.1016/j.bmcl.2005.09.068] |